Item
Amgen’s first-ever LinkedIn Live event featured a conversation between Ray Deshaies, Amgen’s Senior VP for Global Research, and Carolyn Bertozzi, a Professor of Chemistry at Stanford University, investigator of the Howard Hughes Medical Institute, and Baker Family Co-Director at Stanford ChEM-H. In the event, held on October 5, 2020, Ray and Carolyn explored the future of multispecific medicines, and their discussion was viewed live by more than 500 people around the world.
To watch the replay, visit Amgen’s LinkedIn page to view the discussion at this link.